BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines other Collaboration Revenue ($M, FY17–FY22) ($M)
Form 10-Q / 10-K Collaboration Note
Latest, FY2022
9.50
Period ended Dec 31, 2022
Change on a year earlier
–
0 in FY2021
History
6 years
Since FY2017
Sources
4
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Collaboration Revenue ($M, FY17–FY22) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2022 | Dec 31, 2022 | 9.50 | – | Form 10-K (filed 2023-02-27) ↗ |
| FY2021 | Dec 31, 2021 | 0 | – | Form 10-K (filed 2023-02-27) ↗ |
| FY2020 | Dec 31, 2020 | 0 | – | Form 10-K (filed 2022-02-28) ↗ |
| FY2019 | Dec 31, 2019 | 0 | – | Form 10-K (filed 2023-02-27) ↗ |
| FY2018 | Dec 31, 2018 | 0 | – | Form 10-K (filed 2021-02-25) ↗ |
| FY2017 | Dec 31, 2017 | 0 | – | Form 10-K (filed 2020-03-02) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Other Collaboration Revenue ($M, FY17–FY22) ($M), annual FY2017–FY2022 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/rev_collab_other
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.